Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
Managers
NameAgeSinceTitle
Andrew Philip Witty492008Chief Executive Officer & Executive Director
Christopher Charles Gent652004Non-Executive Chairman
Simon Dingemans502011Chief Financial Officer & Executive Director
Moncef Slaoui, PhD652006Director, Chairman-Global Research & Development
William C. Louv, PhD--Chief Information Officer
James Samuel Shannon, MD582012Chief Medical Officer
Deryck Charles Maughan662004Senior Independent Non-Executive Director
Tom de Swaan682006Independent Non-Executive Director
Stephanie A. Burns, PhD592007Independent Non-Executive Director
Daniel K. Podolsky, PhD602006Independent Non-Executive Director
Shareholders
NameShares%
BlackRock Investment Management (UK) Ltd. 184,340,3133.80%
Invesco Asset Management Ltd. 178,053,3543.67%
Legal & General Investment Management Ltd. 162,498,9273.35%
BlackRock Advisors LLC 99,873,6292.06%
Norges Bank Investment Management 90,629,1511.87%
Scottish Widows Investment Partnership Ltd. 81,701,7331.68%
M&G Investment Management Ltd. 71,980,0001.48%
The Vanguard Group, Inc. 71,184,8621.47%
GlaxoSmithKline Employee Trust 63,613,5281.31%
State Street Global Advisors Ltd. 62,029,1811.28%
Holdings
NameShares%Valuation
Aspen Pharmacare Holdings Limited (APNJ) 56,570,78012.4%1,684,868,472 USD
Theravance Biopharma Inc 8,299,21825.7%191,296,975 USD
Genmab A/S (GEN) 4,471,2027.87%189,692,399 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%148,380,643 USD
Amicus Therapeutics, Inc. (FOLD) 11,315,82514.4%67,329,159 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6939.44%55,518,691 USD
GALAPAGOS (GLPG) 508,6441.68%7,697,686 USD
Allergy Therapeutics plc (AGY) 10,118,0002.47%3,936,711 USD
Response Genetics, Inc. (RGDX) 5,000,00012.9%3,425,000 USD
Serendex Pharmaceuticals A/S 98,0100.65%120,858 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
GLAXOSMITHKLINE P..
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
ALLERGAN, INC.
TEVA PHARMACEUTIC..
VALEANT PHARMACEU..
REGENERON PHARMAC..
SHIRE PLC
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
Sector Pharmaceuticals
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
Great-Britain

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE Eurotop 100, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF